InspireMD Inc. Daily Stock Analysis

Daily Stock Analysis, NSPR, InspireMD Inc, priceseries

InspireMD Inc. Daily Stock Analysis
Stock Information
Open
2.60
Close
2.63
High
2.76
Low
2.48
Previous Close
2.62
Daily Price Gain
0.01
YTD High
3.17
YTD High Date
Jan 4, 2022
YTD Low
2.30
YTD Low Date
Jan 28, 2022
YTD Price Change
-0.50
YTD Gain
-15.97%
52 Week High
14.40
52 Week High Date
Mar 15, 2021
52 Week Low
2.30
52 Week Low Date
Jan 28, 2022
52 Week Price Change
-9.22
52 Week Gain
-77.81%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Oct 24. 2017
337.50
Oct 25. 2017
356.25
1 Trading Days
5.56%
Link
LONG
Nov 7. 2017
307.50
Nov 8. 2017
326.25
1 Trading Days
6.10%
Link
LONG
May 2. 2018
937.50
May 4. 2018
986.25
2 Trading Days
5.20%
Link
LONG
Aug 20. 2019
38.70
Aug 21. 2019
56.85
1 Trading Days
46.90%
Link
LONG
Sep 6. 2019
38.85
Sep 11. 2019
40.88
3 Trading Days
5.21%
Link
LONG
Sep 17. 2019
49.20
Sep 19. 2019
58.35
2 Trading Days
18.60%
Link
LONG
Apr 8. 2020
9.15
Apr 21. 2020
10.85
8 Trading Days
18.57%
Link
LONG
Nov 10. 2020
5.40
Nov 11. 2020
5.70
1 Trading Days
5.56%
Link
LONG
Jan 4. 2021
6.60
Jan 19. 2021
8.12
10 Trading Days
23.07%
Link
LONG
Jan 25. 2021
11.55
Jan 26. 2021
12.45
1 Trading Days
7.79%
Link
LONG
Feb 5. 2021
12.30
Feb 18. 2021
15.57
8 Trading Days
26.62%
Link
LONG
Aug 9. 2021
3.99
Aug 10. 2021
4.22
1 Trading Days
5.76%
Link
Company Information
Stock Symbol
NSPR
Exchange
NYSE MKT
Company URL
http://http://www.inspire-md.com
Company Phone
(888) 776-6804
CEO
James J. Barry
Headquarters
Massachusetts
Business Address
4 MENORAT HAMAOR ST., TEL AVIV, ISRAEL 6744832
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0001433607
About

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex coronary and vascular diseases.

Description

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex coronary and vascular diseases. It offers MGuard prime embolic protection systems for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions; and CGuard carotid embolic prevention systems for use in carotid artery applications. The company is also developing NVGuard, a neurovascular flow diverter that diverts blood flow away from cerebral aneurysms and seals the aneurysms. InspireMD, Inc. distributes its products in Europe, Latin America, the Middle East, and Asia. The company is headquartered in Tel Aviv, Israel.

TCHANNELS® is a Registered Trademark with USPTO

Some images used on this site have been taken from Unsplash

Legal Information

Useful Links

Contact Us

PO Box 2574, Sunnyvale
California 94087-0574, USA
Phone: 408-940-5056
Email: Click to send us an Email

Risks of Algorithmic Trading: Before investing please read our disclosure on Risks of Algorithmic Trading.

DISCLAIMER All investments entail inherent risk. This research seeks to assist investors in determining when to buy and when to sell to attempt to maximize profits or minimize losses. All final investment decisions are yours and as a result you could make or lose money. priceSeries.com, its employees and/or its affiliates and family members may from time to time take positions in the open market or otherwise with respect to the securities discussed. priceSeries.com, its employees and/or affiliates do not have stock ownership equal to or greater than 1% of the outstanding stock of the covered company nor does any employee of priceSeries.com sit on the Board of Directors of any covered company. priceSeries.com is not a broker/dealer, and the firm does not underwrite securities, manage assets or perform investment banking activities. The statements made herein include information obtained from sources believed to be reliable, but no independent verification has been made and we do not guarantee its accuracy or completeness.

U.S. Government Required Disclaimer - Commodity Futures Trading Commission
Futures and Options trading has large potential rewards, but also large potential risk. You must be aware of the risks and be willing to accept them in order to invest in the futures and options markets. Don't trade with money you can't afford to lose. This is neither a solicitation nor an offer to Buy/Sell futures or options. No representation is being made that any account will or is likely to achieve profits or losses similar to those discussed on this web site. The past performance of any trading system or methodology is not necessarily indicative of future results.

CFTC RULE 4.41 - HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING. ALSO, SINCE THE TRADES HAVE NOT BEEN EXECUTED, THE RESULTS MAY HAVE UNDER-OR-OVER COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFIT OR LOSSES SIMILAR TO THOSE SHOWN.

2016 © priceSeries.com All Rights Reserved. Privacy Policy | Subscriber Agreement | Risks of Algorithmic Trading